India, April 27 -- NOVONIX Limited (NVX, NVX.AX) announced Sunday that it appointed Michael OKronley as its Chief Executive Officer, effective May 19, 2025. OKronley succeeds Robert Long, who has serv... Read More
India, April 27 -- Hong Kong will on Monday see March figures for imports and exports, highlighting a very light day for Asia-Pacific economic activity. In February, imports were up 11.8 percent on m... Read More
India, April 27 -- Pfizer Inc. (PFE) announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care ... Read More
India, April 27 -- Johnson & Johnson (JNJ)today announced new data from Cohort 2 of the pivotal Phase 2b SunRISe-1 study evaluating TAR-200-an intravesical gemcitabine releasing system-for patients wi... Read More
India, April 27 -- Johnson & Johnson (JNJ) announced first results from Cohort 4 of the Phase 2b SunRISe-1 study evaluating TAR-200-an intravesical gemcitabine releasing system-for patients with certa... Read More
India, April 27 -- Medtronic (MDT) revealed that its Expand URO Investigational Device Exemption (IDE) clinical study, the most extensive of its kind for robotic-assisted urologic surgery, successfull... Read More
India, April 27 -- Abbott (ABT) announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months for patients receiving pulsed field ablation (PFA) therapy with the... Read More
India, April 27 -- Medtronic plc (MDT) announced positive clinical outcomes from two studies in atrial fibrillation (AFib) patients treated with the Affera family of technologies, including the next-g... Read More
India, April 26 -- Valneva SE (VALN) announced that France's national public health agency, the Haute Autorite de Sante (HAS), has updated its recommendation for use of Valneva's single-dose chikungun... Read More
India, April 26 -- UroGen Pharma Ltd. (URGN) announced encouraging safety data from the Phase 1 dose-escalation study for UGN-301 (zalifrelimab) intravesical solution, an investigational drug in devel... Read More